1. Home
  2. Labeler Index
  3. Hikma Pharmaceuticals Usa Inc.
  4. 0143-9877
  5. Product Images: Cefoxitin

Product Images Cefoxitin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Cefoxitin NDC 0143-9877 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical structure - cefoxitin for injection 1

Chemical structure - cefoxitin for injection 1

NDC 0143-9878-01 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY * Each vial contains cefoxitin sodium equivalent to 1 g cefoxitin. The sodium content is 53.8 mg (2.3 mEq). For the preparation of IV solutions and the USUAL ADULT DOSAGE: See package insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC (41ºF)). Store dry material between 2º to 25ºC (36º to 77ºF). Avoid exposure to temperatures above 50ºC (122ºF). Color changes in powder or solution do not affect potency. Date/Time _________________ / _________________ - cefoxitin for injection 2

NDC 0143-9878-01 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY * Each vial contains cefoxitin sodium equivalent to 1 g cefoxitin. The sodium content is 53.8 mg (2.3 mEq). For the preparation of IV solutions and the USUAL ADULT DOSAGE: See package insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC (41ºF)). Store dry material between 2º to 25ºC (36º to 77ºF). Avoid exposure to temperatures above 50ºC (122ºF). Color changes in powder or solution do not affect potency. Date/Time _________________ / _________________ - cefoxitin for injection 2

25 x 1 g* Vials NDC 0143-9878-25 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY - cefoxitin for injection 3

25 x 1 g* Vials NDC 0143-9878-25 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY - cefoxitin for injection 3

CEFOXITIN FOR INJECTION, USP is an intravenous medication used to treat various bacterial infections. The medication is manufactured by Hikma Farmaceutica in Portugal and distributed by West-Ward in New Jersey. Each vial contains cefoxitin sodium equivalent to 1g of cefoxitin, and the sodium content is 53.8mg (2.3mEq). The medication can be stored at room temperature or under refrigeration, and after initial constitution, the solution maintains its potency for 48 hours. The medication is sold in a package of 25 vials.*

25 x 1 g* Vials NDC 0143-9878-25 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY *Each vial contains cefoxitin sodium equivalent to 1 g cefoxitin. The sodium content is 53.8 mg (2.3 mEq). For the preparation of I.V. Solutions and USUAL ADULT DOSAGE: See Package Insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC). Store dry material between 2-25ºC (36-77ºF). Avoid exposure to temperatures above 50ºC. Color changes in powder or solution do not affect potency. - cefoxitin for injection 4

25 x 1 g* Vials NDC 0143-9878-25 CEFOXITIN FOR INJECTION, USP 1 g*/vial FOR IV USE ONLY Rx ONLY *Each vial contains cefoxitin sodium equivalent to 1 g cefoxitin. The sodium content is 53.8 mg (2.3 mEq). For the preparation of I.V. Solutions and USUAL ADULT DOSAGE: See Package Insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC). Store dry material between 2-25ºC (36-77ºF). Avoid exposure to temperatures above 50ºC. Color changes in powder or solution do not affect potency. - cefoxitin for injection 4

This is a description of an injectable medication called Cefoxitin for intravenous use. The medication comes in 2g vials and each vial contains Cefoxitin sodium equivalent. The standard adult dosage is provided on the package insert. After it is constituted, the solution remains potent at room temperature for 6 hours or for 1 week if refrigerated. Storage requirements and precautions against temperature exposure are also listed. The product was made by Hrmafarmaceutica in Portugal and distributed by Westauard Pharmaceutical Company in the United States. Lot and expiration date information is also provided.*

NDC 0143-9877-01 CEFOXITIN FOR INJECTION, USP 2 g*/vial FOR IV USE ONLY Rx ONLY * Each vial contains cefoxitin sodium equivalent to 2 g cefoxitin. The sodium content is 107.6 mg (4.6 mEq). For the preparation of IV solutions and the USUAL ADULT DOSAGE: See package insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC (41ºF)). Store dry material between 2º to 25ºC (36º to 77ºF). Avoid exposure to temperatures above 50ºC (122ºF). Color changes in powder or solution do not affect potency. Date/Time _________________ / _________________ - cefoxitin for injection 5

NDC 0143-9877-01 CEFOXITIN FOR INJECTION, USP 2 g*/vial FOR IV USE ONLY Rx ONLY * Each vial contains cefoxitin sodium equivalent to 2 g cefoxitin. The sodium content is 107.6 mg (4.6 mEq). For the preparation of IV solutions and the USUAL ADULT DOSAGE: See package insert. After initial constitution, the solution maintains satisfactory potency for 6 hours at room temperature or for 1 week under refrigeration (below 5ºC (41ºF)). Store dry material between 2º to 25ºC (36º to 77ºF). Avoid exposure to temperatures above 50ºC (122ºF). Color changes in powder or solution do not affect potency. Date/Time _________________ / _________________ - cefoxitin for injection 5

This is a description of Cefoxitin injection, a medication used for intravenous (IV) use only. Each vial contains 2g of cefoxitin sodium and the medication is made by HIKMA FARMACEUTICA (PORTUGAL), SA. The package insert contains instructions for preparation of the IV solution and usual adult dosage. After initial preparation, the solution can be stored at room temperature for up to 8 hours or refrigerated for up to 1 week. The medication should be stored at temperatures between 2°C and 25°C (36°F and 77°F) and protected from temperatures above 50°C. Color changes in the powder or solution do not affect potency.*

25 x 2 g* Vials NDC 0143-9877-25 CEFOXITIN FOR INJECTION, USP 2 g*/vial FOR IV USE ONLY Rx ONLY - cefoxitin for injection 6

25 x 2 g* Vials NDC 0143-9877-25 CEFOXITIN FOR INJECTION, USP 2 g*/vial FOR IV USE ONLY Rx ONLY - cefoxitin for injection 6

This appears to be a product label or packaging with a Global Trade Item Number (GTIN), Serial Number (SN), Expiration Date (EXP), and Lot Number (LOT) for identification and tracking purposes. However, without more information on the product or company, the purpose or contents of the label cannot be determined.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.